spacer
home > > summer 2019 > the changing face of clinical data
PUBLICATIONS


The Changing Face of Clinical Data




Data collection and analysis have always been central to the development of new clinical interventions such as drug treatments, diagnostics, and medical devices. While clinical data have always been collected and analysed, in recent years emerging methods and technologies for collection, analysing and utilising data, as well as the sheer quantity of data collected have been changing, driven by innovation and an evolving drug development landscape.

Clinical data can take many forms, but are essentially any information collected about an individual over the course of their admission and treatment in a medical setting. These data can range from their medical record information (such as age and medical history), the clinical interventions they undergo (such as blood tests, drugs prescribed, and surgical procedures), and the resulting outcomes following an intervention. These measures form the basis of any clinical trial that seeks to establish the efficacy or safety of a novel drug treatment, medical device, or diagnostic.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Aiden Flynn is the Founder of Exploristics and has more than 20 years’ experience in drug discovery and clinical development. After seven years as a lecturer at University College London, UK, Aiden spent 10 years at GlaxoSmithKline as a Director of statistical support for biomarker studies across R&D. In recent years, he has worked closely with the FDA and EMEA to develop tools and guidelines that support the use of biomarkers in clinical studies. Since founding Exploristics in 2009, Aiden has attracted over 50% of the world’s top pharma companies as clients, as well as many biotechnology, device, and diagnostic companies.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Pharmapack Europe 2020 Award Winners Announced

Exhibitor Innovations 1. Best Innovation in Drug Delivery Device (injectable): The Connect™ Auto-Sensing Injection System by Credence MedSystems 2. Best Innovation in Drug Delivery Device (respiratory): Safe'n'Spray™ by NEMERA 3. Best Innovation in Primary Packaging (solid dosage): Push Tab® loop by Huhtamaki Flexible Packaging 4. Best Innovation in Primary Packaging (liquid dosage): Pourer “Lotus” by PACKSYS GmbH 5. Best Innovation in Secondary Packaging: Patient Support App by Rondo 6. Best Innovation in Machinery: Quantifeel Quality Assurance Platform by Smart Skin Technologies
More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement